Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Redhill Biopharma Ltd. (RDHL : NSDQ)

• Company Description    RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. Number of Employees: 35

• Price / Volume Information    Yesterday's Closing Price: $2.13 Daily Weekly Monthly 20 Day Moving Average: 16,959 shares Shares Outstanding: 2.30 (millions) Market Capitalization: $4.89 (millions) Beta: 4.22 52 Week High: $20.28 52 Week Low: $1.71 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.79% 5.68% 12 Week -5.75% -20.73% Year To Date -65.70% -67.88%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 21 Ha'arba'a Street - Tel Aviv,L3 64739 ISR ph: 972-3541-3131 fax: 972-3541-3144 investors@redhillbio.com http://www.redhillbio.com

• General Corporate Information    Officers Dror Ben-Asher - Chief Executive Officer and Chairman Gilead Raday - Chief Operating Officer Razi Ingber - Chief Financial Officer Dr. Shmuel Cabilly - Director Ofer Tsimchi - Director Peer Information Redhill Biopharma Ltd. (GSAC) Redhill Biopharma Ltd. (CASI) Redhill Biopharma Ltd. (ALCD.) Redhill Biopharma Ltd. (OMNN) Redhill Biopharma Ltd. (CGPI.) Redhill Biopharma Ltd. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 757468301 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 2.30 Most Recent Split Date: 8.00 (0.04:1) Beta: 4.22 Market Capitalization: $4.89 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 0.54 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 0.37 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -102.80 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - -3.66 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 0.86 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©